PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Battle of the sexes, fruit-fly style

2010-11-24
(Press-News.org) BOSTON, Mass. (Nov. 23, 2010) — Pity the female fruit fly. Being a looker is simply not enough. To get a date, much less a proposal, you have to act like a girl, even smell like one. Otherwise, you might just have a fight on your hands.

Like most animals, fruit flies must distinguish between a potential mate and a potential competitor. When a male fruit fly suspects he's encountered a female, he'll court; when he senses the other is a male, he'll fight. What triggers these sex-specific responses?

According to new research by scientists at Harvard Medical School, the answer lies with both pheromonal profiles and behavioral patterns. The researchers investigated the effects of taste and action by manipulating a gene that governs both the sex specificity of a fruit fly's body-surface hydrocarbons, or pheromones, and the sex-linked behavioral cues that issue through the dense nerve-cell network that constitutes the fly's brain.

"These findings underscore the importance of behavioral feedback in the manifestation of aggression," says Edward Kravitz, the George Packer Berry Professor of Neurobiology at Harvard Medical School.

The research is published in the November 23 issue of PLoS Biology.

María de la Paz Fernández and Yick-Bun Chan, post-doctoral researchers in the Kravitz lab, discovered these links to aggression when investigating whether a male fruit fly would ever attack a female. They focused on a particular gene called transformer, which is active in females but not in males. Through blocking transformer expression in a variety of different tissues in females, the researchers could specifically alter the "femaleness" or "maleness" of the pheromones, which in turn altered the patterns of aggressive behavior encoded in the fly's brain.

When they changed pheromone profiles so that females "tasted" like males, the researchers found that males would attack them. This indicated that pheromonal cues alone could label another fly as a competitor. But the researchers were surprised to discover that males also attacked "aggressive females"—flies that still looked, smelled and tasted female but had been genetically altered to display male-like patterns of behavior.

When the researchers turned the tables by triggering the expression of transformer in males so as to feminize both the pheromonal and behavioral profiles, control males showed no aggression toward the transformed males. Instead, they began to court them. These results show that it is possible to completely reverse normal behavioral responses by presenting males with unanticipated and conflicting sensory cues.

"Future studies will aim at unraveling the neuronal circuitry that governs this type of decision-making behavior, as such decisions are essential for survival," says Kravitz. "With the powerful genetic methods available in fly neurobiology, it should be possible to dissect the decision-making circuitry at far greater levels of detail than have heretofore been possible in other species."

"This study addresses a classic question in animal behavior: What motivates an individual to do X rather than Y, or vice versa," said Laurie Tompkins, Ph.D., who manages Kravitz's and other behavioral genetics grants at the National Institutes of Health. "Because the general principles of how behaviors are controlled are conserved among species, Kravitz's conclusions about how flies make simple choices may illuminate how humans and other animals make more complex decisions."

INFORMATION:

The study was supported by grants from the National Institute of General Medical Science and by a Pew Latin American Fellowship awarded to Fernández.

Written by Ann Marie Menting.

CITATION: PLoS Biology, 8(11): e1000541; doi:10.1371/journal.pbio.1000541, Nov 23, 2010

"Pheromonal and Behavioral Cues Trigger Male-to-Female Aggression in Drosophila"

María de la Paz Fernández (1), Yick-Bun Chan (1), Joanne Y. Yew (2,3,4), Jean-Christophe Billeter (5), Klaus Dreisewerd (3), Joel D. Levine (5), Edward A. Kravitz (1)

(1) Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA
(2) Temasek Life Sciences Laboratories, 1 Research Linkn National University of Singapore, Singapore
(3) Institute of Medical Physics and Biophysics, Westfälische Wilhelms-Universität Münster, Münster, Germany
(4) Department of Biological Sciences, National University of Singapore, Singapore
(5) Department of Biology, University of Toronto at Mississauga, Mississauga, Ontario, Canada

Harvard Medical School has more than 7,500 full-time faculty working in 11 academic departments located at the School's Boston campus or in one of 47 hospital-based clinical departments at 17 Harvard-affiliated teaching hospitals and research institutes. Those affiliates include Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Cambridge Health Alliance, Children's Hospital Boston, Dana-Farber Cancer Institute, Forsyth Institute, Harvard Pilgrim Health Care, Hebrew SeniorLife, Joslin Diabetes Center, Judge Baker Children's Center, Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, McLean Hospital, Mount Auburn Hospital, Schepens Eye Research Institute, Spaulding Rehabilitation Hospital, and VA Boston Healthcare System.

END



ELSE PRESS RELEASES FROM THIS DATE:

Tigers and polar bears are highly vulnerable to environmental change

Tigers and polar bears are highly vulnerable to environmental change
2010-11-24
Large predators are much more vulnerable than smaller species to environmental changes, such as over-hunting and habitat change, because they have to work so hard to find their next meal, according to a new study. Scientists matched studies of predator populations to the abundance of their prey and found that the largest species, such as lions, tigers or polar bears, had much greater declines in population due to diminishing food supplies than smaller species, such as weasels or badgers. The review of studies of eleven species of carnivores by researchers from Durham ...

AIDS drug shown to prevent HIV in multinational trial of HIV-negative gay men

2010-11-24
Chicago, November 23, 2010 – Results of the world's first efficacy trial of an HIV-prevention approach called oral pre-exposure prophylaxis, or PrEP, were released online in the New England Journal of Medicine today. Data from this trial, called iPrEx, indicated an estimated 43.8% reduction of new HIV infections among men who took an antiretroviral tablet daily to prevent HIV, compared to those who took a placebo pill. "This discovery alters the HIV prevention landscape forever. While this level of efficacy is relatively strong, PrEP is not quite ready for prime time ...

Study shows antiretroviral drugs can prevent HIV in men who have sex with men

2010-11-24
PITTSBURGH, Nov. 23, 2010 – In a significant advance for HIV prevention research, a clinical trial confirms that the same drugs used for treating HIV can also help prevent HIV infection in the first place. The study, known as iPrEx, is important because it gives credence to an HIV prevention approach called oral pre-exposure prophylaxis (PrEP), which involves the use of antiretrovirals (ARVs) by people who are HIV-negative and at high risk of infection. It is the first of five large-scale effectiveness trials testing oral PrEP to report results, which were published online ...

Frequently asked questions about PrEP and the iPrEx trial

2010-11-24
The results of the iPrEx PrEP effectiveness trial of once-daily TDF/FTC (brand name Truvada) in gay men, transgender women and other men who have sex with men are a landmark in HIV prevention research. The results, released on November 23, showed that TDF/FTC reduced risk of HIV infection by an average of 43.8%. This was calculated by looking at rates of infections among participants who received TDF/FTC plus a standard prevention package compared to those in the placebo arm who received a look-alike pill with no active drug, along with the prevention package. All of the ...

Binge drinking may lead to higher risk of heart disease

2010-11-24
Belfast's binge drinking culture could be behind the country's high rates of heart disease, according to a paper published on bmj.com today. The study, which compares drinking patterns of middle aged men in France and Belfast, finds that the volume of alcohol consumed over a week in both countries is almost identical. However, in Belfast alcohol tends to be drunk over one or two days rather than regularly throughout the week as in France. The research also finds that the average amount of alcohol consumed in Belfast over the weekend is around 2-3 times higher than ...

Age restriction on emergency stroke treatment should be lifted, say researchers

2010-11-24
Thrombolysis (giving anti-clotting drugs within three hours of an acute stroke) is effective in patients aged 40 to 90 years and should not be restricted in elderly patients, as current guidelines advise, concludes a study published on bmj.com today. Thrombolysis for acute ischaemic stroke has proven benefits, but it is currently not recommended for patients over 80 years because of a lack of trial data for this group. Effective treatments, however, should not be withheld from older people in the absence of compelling data suggesting unacceptable risk or proved lack of ...

Retirement reduces tiredness and depression

2010-11-24
Retirement leads to a substantial reduction in mental and physical fatigue and depressive symptoms, finds a study published on bmj.com today. However, the research also concludes that retirement does not change the risk of major chronic illnesses such as respiratory disease, diabetes and heart disease. The authors, led by Dr Hugo Westerlund from Stockholm University, say their research findings have important implications given that people will be working for longer and retiring later in life. Retirement is a major life transition, says the study. But the results of ...

Too much of a good thing: Important mechanism in hormone-sensitive breast cancer uncovered

2010-11-24
Two thirds of breast cancers are ERalpha-positive, i.e., many estrogen receptors of the ERalpha- type are found in their cells. "These molecules can interact with the estrogen hormone and, thus, even lead to cancer," explains Dr. Joerg Hoheisel; molecular biologist at DKFZ. "The connection between the levels of the estrogen receptor alpha and the occurrence of breast cancer has been known for some time now. Early-stage breast cancer cells already produce too many of these receptors. This is associated with increased cell division, which is ultimately responsible for tumor ...

Under suspicion: The painkiller ziconotide could increase suicidal ideation

2010-11-24
The active agent ziconotide, the synthetic toxin of the cone snail (Conus magus), was acclaimed a safe alternative to morphine when it was introduced six years ago. Now it is increasingly suspected of causing patients to commit suicide. Researchers working under the auspices of Prof. Christoph Maier (Director of the Pain Clinic Bergmannsheil at the Ruhr University in Bochum) presume that ziconotide not only suppresses the transmission of pain stimuli, but also deteriorates the frame of mind and could simultaneously reduce anxiety and impulse control. These mechanisms could ...

Dealt a bad hand: Pathological gamblers are also at risk for mental health disorders

2010-11-24
Montreal, November 23, 2010 – Pathological gamblers are risking more than their money, they are also three times more likely to commit suicide than non-betters. A new Montreal inter-university study has shown these gamblers are also plagued by personality disorders. These findings, published in a recent issue of the Psychology of Addictive Behaviors, may have implications for developing improved targeted suicide prevention programs. "The World Health Organization estimates that suicide is one of the top ten causes of death in the Western world," says study co-author, ...

LAST 30 PRESS RELEASES:

Students with multiple marginalized identities face barriers to sports participation

Purdue deep-learning innovation secures semiconductors against counterfeit chips

Will digital health meet precision medicine? A new systematic review says it is about time

Improving eye tracking to assess brain disorders

Hebrew University’s professor Haitham Amal is among a large $17 million grant consortium for pioneering autism research

Scientists mix sky’s splendid hues to reset circadian clocks

Society for Neuroscience 2024 Outstanding Career and Research Achievements

Society for Neuroscience 2024 Early Career Scientists’ Achievements and Research Awards

Society for Neuroscience 2024 Education and Outreach Awards

Society for Neuroscience 2024 Promotion of Women in Neuroscience Awards

Baek conducting air quality monitoring & simulation analysis

Albanese receives funding for scholarship grant program

Generative AI model study shows no racial or sex differences in opioid recommendations for treating pain

New study links neighborhood food access to child obesity risk

Efficacy and safety of erenumab for nonopioid medication overuse headache in chronic migraine

Air pollution and Parkinson disease in a population-based study

Neighborhood food access in early life and trajectories of child BMI and obesity

Real-time exposure to negative news media and suicidal ideation intensity among LGBTQ+ young adults

Study finds food insecurity increases hospital stays and odds of readmission 

Food insecurity in early life, pregnancy may be linked to higher chance of obesity in children, NIH-funded study finds

NIH study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry

New study reveals changes in the brain throughout pregnancy

15-minute city: Why time shouldn’t be the only factor in future city planning

Applied Microbiology International teams up with SelectScience

Montefiore Einstein Comprehensive Cancer Center establishes new immunotherapy institute

New research solves Crystal Palace mystery

Shedding light on superconducting disorder

Setting the stage for the “Frankfurt Alliance”

Alliance presents final results from phase III CABINET pivotal trial evaluating cabozantinib in advanced neuroendocrine tumors at ESMO 2024 and published in New England Journal of Medicine

X.J. Meng receives prestigious MERIT Award to study hepatitis E virus

[Press-News.org] Battle of the sexes, fruit-fly style